The FGF18 and FGF22 genes are known to play a role in heart development and physiological processes [69] while the MYC gene is implicated in angiogenesis, cardiomyogenesis, apoptosis, oxidative stress response and plays a major role in initiating and maintaining cardiac hypertrophy and contractility [70]. This evidence concerns the gene FGF22 and cardiac hypertrophy.